3663-22-7

Basic information

• Product Name: 4-butyl-2-nitroaniline
• Synonyms: 4-butyl-2-nitroaniline;4-Butyl-2-nitrobenzenamine;Einecs 222-916-1;4-butyl-2-nitroaniline C10H14N2O2 194.23
• CAS NO: 3663-22-7
• Molecular Formula: C₁₀H₁₄N₂O₂
• Molecular Weight: 194.23036
• EINECS: 222-916-1
• Mol File: 3663-22-7.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 338.3°Cat760mmHg
• Flash Point: 158.4°C
• Appearance: /
• Density: 1.146g/cm³
• Vapor Pressure: 9.91E-05mmHg at 25°C
• Refractive Index: 1.573
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 4-butyl-2-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-butyl-2-nitroaniline(3663-22-7)
• EPA Substance Registry System: 4-butyl-2-nitroaniline(3663-22-7)

Safety Data

• Hazardous Substances Data: 3663-22-7(Hazardous Substances Data)

Usage

General Description

4-butyl-2-nitroaniline is an organic compound with the chemical formula C10H14N2O2. It is a nitro-substituted aniline, containing a nitro group and a butyl group. 4-butyl-2-nitroaniline is commonly used in the manufacturing of dyes, pigments, and pharmaceuticals. It is orange-red in color and is insoluble in water but soluble in organic solvents. 4-butyl-2-nitroaniline is also known for its use as a corrosion inhibitor in metal processing and as a component in the synthesis of other organic compounds. However, it is important to note that 4-butyl-2-nitroaniline may pose health hazards if not handled carefully, as it is considered a toxic substance and proper safety measures should be taken when working with it.

InChI:InChI=1/C10H14N2O2/c1-2-3-4-8-5-6-9(11)10(7-8)12(13)14/h5-7H,2-4,11H2,1H3

Upstream product

• 104-51-8 1-butylbenzene 
• 20651-75-6 1-butyl-4-nitro-benzene 
• 104-13-2 4-Butylaniline 
• 3663-20-5 N-(4-butylphenyl)acetamide 
• 3663-21-6 N-(4-butyl-2-nitrophenyl)acetamide 
• 62-53-3 aniline 
• 1126-78-9 N-(n-butyl)aniline 

Downstream Products

• 35204-21-8 1-ethoxycarbonyl-3-(5-n-butyl-2-dimethylaminoacetamidophenyl)thiourea 
• 35266-41-2 1-methoxycarbonyl-3-(4-n-butyl-2-ethoxycarbonylaminophenyl)thiourea 
• 35266-40-1 C₁₇H₂₃N₃O₃S 
• 35198-81-3 C₁₆H₂₃N₃O₄S 
• 35198-78-8 C₁₇H₂₃N₃O₃S 
• 35198-80-2 C₁₄H₁₉N₃O₃S 
• 35277-99-7 1-methoxycarbonyl-3-(4-n-butyl-2-formamidophenyl)thiourea 
• 35266-36-5 C₁₄H₂₁N₃O₂S 
• 35204-31-0 N-(2-amino-4-n-butylphenyl)-2-dimethylaminoacetamide 
• 35198-85-7 Cyclopropanecarboxylic acid (2-amino-4-butyl-phenyl)-amide 
• 35198-86-8 N-(2-Amino-4-butyl-phenyl)-formamide 
• 35266-34-3 1-methoxycarbonyl-3-(2-amino-4-n-butylphenyl)thiourea 
• 103853-61-8 5-butyl-1,3-dihydro-benzimidazol-2-one 
• 5369-17-5 m-(n-butyl)-aniline 

Relevant articles and documents

-

-

A Systematic Study on the Synthesis of n-Butyl Substituted 8-Aminoquinolines

(Chemical Equation Presented) A systematic study on the synthesis of 8-aminoquinoline derivatives with an n-butyl group at each alternate position of the quinoline ring was carried out. Skraup Reaction and its Doebner-von Miller variation were used to obtain most of the quinoline ring except for the 2-butyl-8-aminoquinolines and 4-butyl-8-aminoquinolines where the commercially available methylquinoline derivatives were used as precursors. The structures of the synthesized compounds were characterized by FTIR, 1H-NMR, COSY, 13C-NMR and HRMS spectra.

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

The compounds represented by Formula (I) or pharmaceutically acceptable salts thereof: with U, W, X, Y, Z, p and ring A as defined in claim 1. Those compounds are useful for the treatment or prevention of bacteria infections. The variables of Formula (I) are as described herein. Pharmaceutically acceptable compositions comprise the compounds of Formula (I) or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers, adjuvants, or vehicles. Methods of treating bacteria infections employ such compounds or pharmaceutically acceptable salts thereof.